Mycophenolate mofetil ameliorates nephropathy in the obese Zucker rat

Kidney International

Volumn 68, Issue 3, 2005, Pages 1041-1047

  Rodríguez Iturbe, Bernardo ^a   Quiroz, Yasmir ^b   Shahkarami, Ashkan ^b   Li, Zhen ^b   Vaziri, Nosratola D ^b  

^a HOSPITAL UNIVERSITARIO DE MARACAIBO   (Venezuela)

^b NONE

Author keywords

Diabetic nephropathy; Glomerulosclerosis; Immunosuppression; Lymphocytes; Macrophages

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DRINKING WATER; LOSARTAN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PLACEBO;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DRUG EFFICACY; GLOMERULUS BASEMENT MEMBRANE; IMMUNOHISTOLOGY; INTERSTITIAL NEPHRITIS; KIDNEY DISEASE; KIDNEY FUNCTION TEST; KIDNEY INJURY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RANDOMIZATION; RAT; RAT STRAIN; SPECIES COMPARISON; TREATMENT OUTCOME;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DRUG THERAPY, COMBINATION; IMMUNOSUPPRESSIVE AGENTS; LOSARTAN; MALE; MYCOPHENOLIC ACID; OBESITY; RATS; RATS, ZUCKER;

EID: 32644457806     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2005.00496.x     Document Type: Article

References (27)

1. ZUCKER LM: Hereditary obesity in the rat associated with hyperlipidemia. Ann NY Acad Sci 131:447-458, 1965
2. BRAY GA: The Zucker fatty rat: A review. Fed Proc 36:148-153, 1977
3. KASISKE BL, O'DONNELL MP, KEANE WF: The Zucker rat model of obesity, insulin resistance, hyperlipidemia, and renal injury. Hypertension 19:1110-1115, 1992
4. KASISKE BL, CLEARY MP, O'DONNELL MP, KEANE WF: Effects of genetic obesity on renal structure and function in the Zucker rat. J Lab Clin Med 106:598-604, 1985
5. KASISKE BL, CLEARY MP, O'DONNELL MP, KEANE WF: Treatment of hyperlipidemia reduces glomerular injury in obese Zucker rats. Kidney Int 33:667-672, 1988
6. SCHMITZ PG, O'DONNELL MP, KASISKE BL, et al: Renal injury in obese Zucker rats: glomerular hemodynamic alterations and effects of enalapril. Am J Physiol 263:F496-F502, 1992
7. TOBLLI JE, DEROSA G, CAO G, et al: ACE inhibitor and angiotensin type I receptor antagonist in combination reduce renal damage in obese Zucker rats. Kidney Int 65:2343-2359, 2004
8. XU Z-G, LANTING L, VAZIRI ND, et al: Upregulation of angiotensin type 1 receptor, inflammatory mediators and enzymes of arachidonate metabolism in obese Zucker rat kidney: Reversal by angiotensin II type 1 receptor blockade. Circulation 111:1962-1969, 2005
9. LAVAUD S, MICHEL O, SASSY-PRIGENT C, et al: Early influx of glomerular macrophages precedes glomerulosclerosis in the obese Zucker rat model. J Am Soc Nephrol 7:2604-2615, 1966
10. RODRÍGUEZ-ITURBE B, PONS H, HERRERA-ACOSTA J, JOHNSON RJ: The role of immunocompetent cells in non-immune renal diseases. Kidney Int 59:1626-1640, 2001
11. FUJIHARA CK, MALHEIROS DM, ZATZ R, NORONHA ID: Mycophenolate mofetil attenuates renal injury in the rat remnant kidney. Kidney Int 541510-1519, 1998
12. ROMERO F, RODRIGUEZ-ITURBE B, PARRA G, et al: Mycophenolate mofetil prevents the progressive renal failure induced by 5/6 renal ablation.in rats. Kidney Int 55:945-955, 1999
13. UTIMURA R, FUJIHARA CK, MATTAR AL, et al: Mycophenolate mofetil prevents the development of glomerular injury in experimental diabetes. Kidney Int. 63:209-216, 2003
14. REMUZZI G, ZOJA C, GAGLIARDINI E, et al: Combining an antiproteinuric approach with mycophenolate mofetil fully suppresses progressive nephropathy of experimental animals. J Am Soc Nephrol. 10:1542-1549, 1999
15. FUJIHARA CK, NORONHA I, MALHEIROS D, et al: Combined mycophenolate mofetil and losartan therapy arrests established injury in the remnant kidney. J Am Soc Nephrol 11:283-290, 2000
16. RAIJ L, AZAR S, KEANE W: Mesangial immune injury, hypertension and progressive damage in Dahl rats. Kidney Int 26:137-143, 1984
17. QUIROZ Y, PONS H, GORDON KL, et al: Mycophenolate mofetil prevents salt-sensitive hypertension resulting from nitric oxide synthesis inhibition. Am J Physiol Renal Physiol 281:F38-F47, 2001
18. ALVAREZ V, QUIROZ Y, NAVA M, RODRIGUEZ-ITURBE B: Overload proteinuria is followed by salt-sensitive hypertension caused by renal infiltration of immune cells. Am J Physiol Renal Physiol 283:F1132-F1141, 2002
19. RODRIGUEZ-ITURBE B, QUIROZ Y, NAVA M, et al: Reduction of renal immune cell infiltration results in blood pressure control in genetically hypertensive rats. Am J Physiol Renal Physiol 282:F191-F201, 2002
20. PARRA G, HERNANDEZ S, MORENO P, RODRIGUEZ-ITURBE B: Participation of the tubulointerstitium in acute immune-complex nephritis: Interstitial antigen accumulation, cellular infiltrate and MCH class I expression. Clin Exp Immunol 133:44-49, 2003
21. SPETIE DN, TANG Y, ROVIN BH, et al: Mycophenolate therapy of SLE membranous nephropathy. Kidney Int 66:2411-2415, 2004
22. BADID C, VINCENT M, MCGREGOR B, et al: Mycophenolate mofetil reduces myofibroblast infiltration and collagen III deposition in rat remnant kidney. Kidney Int 58:51-61, 2000
23. DUBUS I, VENDRELY M, CHRISTOHER I, et al: Mycophenolic acid antagonizes the activation of cultured human mesangial cells. Kidney Int 62:857-867, 2002
24. DUBUS I, L'AZOU B, GORDIEN M, et al: Cytoskeletal reorganization by mycophenolic acid alters mesangial cell migration and contractility. Hypertension 42:956-961, 2003
25. VAZIRI ND, LIANG K, PARKS JS: Down-regulation of hepatic lecitin:cholesterol acyltransferase gene expression in chronic renal failure. Kidney Int 59:2192-2196, 2001
26. LIANG K, VAZIRI ND: Upregulation of acyl-CoA:cholesterol acyl-transferase in chronic renal failure. Am J Physiol Endocrinol Metab 283:E676-E681, 2002
27. RODRIGUEZ-ITURBE B, SATO T, QUIROZ Y, VAZIRI ND. AT-1 receptor blockade prevents proteinuria, renal failure, hyperlipidemia and glomerulosclerosis in the Imai rat. Kidney Int 66:668-675, 2004